Search - tctmd.com

Displaying 321 - 340 of 391

Sort: Relevancy | Date

Presentation TCT 2014

Long Lesions: How to Implant Multiple Contiguous Scaffolds

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Pieter C. Smits

September 14, 2014

Presentation TCT 2014

Case #2: BRS Sizing in Complex Disease

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Tommaso Gori

September 14, 2014

Presentation TCT 2014

How to Size BRS (and Why This Is Different Than Metallic DES)

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Tommaso Gori

September 14, 2014

Presentation TCT 2014

Case #1: BRS Optimal Lesion Preparation

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Takeshi Kimura

September 14, 2014

Presentation TCT 2014

Why Optimal Lesion Preparation for BRS Is Critical and How to Achieve It

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Dean J. Kereiakes

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation TCT 2014

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Mahmood K. Razavi

September 13, 2014

Presentation BRS 2014

BioResorbable Vascular Scaffolds: Transformational Technology for PCI

Presenter: Manel Sabat?

July 26, 2014

Presentation BRS 2014

BioResorbable Vascular Scaffolds: An In-Depth Look

Presenter: Manel Sabat?

July 25, 2014

Presentation BRS 2014

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

Presenter: Dean J. Kereiakes

July 25, 2014

News Daily News

生物吸收支架表现良好，但是血栓形成引担忧

Todd Neale

July 24, 2014

News Daily News

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Todd Neale

July 24, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

Presentation

GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice

Presenter: Davide Capodanno

July 23, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

News Industry News

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

May 13, 2014

Presentation CIT 2014

Science Behind Bioresorbable Vascular Scaffolds

Presenter: Renu Virmani

March 20, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Advertisement

Long Lesions: How to Implant Multiple Contiguous Scaffolds

Case #2: BRS Sizing in Complex Disease

How to Size BRS (and Why This Is Different Than Metallic DES)

Case #1: BRS Optimal Lesion Preparation

Why Optimal Lesion Preparation for BRS Is Critical and How to Achieve It

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

BioResorbable Vascular Scaffolds: Transformational Technology for PCI

BioResorbable Vascular Scaffolds: An In-Depth Look

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

生物吸收支架表现良好，但是血栓形成引担忧

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

Science Behind Bioresorbable Vascular Scaffolds

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content